Haier Biomedical unveils digital blood management platform, marking its move from equipment vendor to full‑process solution partner
Executive summary: Haier Biomedical presented its digital blood management platform at the ISBT Congress 2026 in Kuala Lumpur. The platform signals the company's transition from selling standalone equipment to offering integrated software‑enabled solutions for blood collection and processing.
Who is involved: Haier Biomedical (SHA: 688139), the ISBT Congress organizers, and potential customers in plasma collection centers, hospitals and blood banks.
Likely next: Haier may pursue pilot installations and seek regulatory clearances for the software component in key markets over the next 12 months.
At the ISBT Congress 2026 in Kuala Lumpur, Haier Biomedical showcased its new digital blood management platform designed for plasma collection centers, hospitals and blood banks. The launch reflects the company's strategy to integrate software and services with its existing hardware offerings, aiming to provide end‑to‑end solutions for blood management. Analysts view the move as a response to growing demand for digital workflow automation in the transfusion medicine sector. No financial terms or adoption figures were disclosed in the announcement.
Timeline
- — Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner (PR Newswire)
Analysis — what this means
Sectors affected
- Blood management equipment
- Plasma collection centers
- Hospital transfusion services